Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

688091 Shanghai Yizhong Pharmaceutical

Watchlist
73.250
+3.840+5.53%
Market Close 12/02 15:00 CCT
High
74.570
Open
69.310
Turnover
146.22M
Low
68.800
Pre Close
69.410
Volume
20.37Klot
Market Cap
10.54B
P/E(TTM)
87.62
52wk High
146.234
Shares
143.89M
P/E(Static)
Loss
52wk Low
31.654
Float Cap
7.63B
Bid/Ask %
-49.47%
Historical High
146.234
Shs Float
104.19M
Volume Ratio
1.85
Historical Low
28.250
Dividend TTM
--
Div Yield TTM
--
P/B
11.20
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.96%
Amplitude
8.31%
Avg Price
71.780
Lot Size
100
Float Cap
7.63B
Bid/Ask %
-49.47%
Historical High
146.234
Shs Float
104.19M
Volume Ratio
1.85
Historical Low
28.250
Dividend TTM
--
Limit Up
83.290
P/B
11.20
Dividend LFY
--
Limit Down
55.530
Turnover Ratio
1.96%
Amplitude
8.31%
Avg Price
71.780
Lot Size
100
Ask
7.69Klot
Bid
11.81Klot
Price Forecast

No Data

News

Comment

No Data

Company Overview More
The company is committed to the development of new dosage forms of antineoplastic drugs and related products. The company is committed to the R & D and industrialization of improved new drugs for antineoplastic drugs, with high-tech talents with the background of polymer materials, pharmaceutical preparations and biology, and mastering the core and key technologies for the synthesis of nano-drug carriers and medicinal polymer excipients. The company's main research and development product is paclitaxel micelles. Paclitaxel micelle is an innovative lyophilized powder injection without polyoxyethylene castor oil and methoxy polyethylene glycol 2000-poly (lactide) copolymer as carrier.
CEO: Jingsong Zhou
Market: --
Listing Date: 09/09/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist